Yong-Sung Kim

19PUBLICATIONS
23CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Preventative health careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 11, 2026
Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer.

Seul-Gi Lee, Myungjee Lee, Hye-Min Lee

|Jul 26, 2024
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.

Jisun Lee, Bomi Kim, Hye-Min Woo

|Oct 19, 2023
Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy.

Keunok Jung, Deok-Han Ko, Jeong-Yun Jang

|Feb 13, 2023
Association between soy products, fruits, vegetables, and dairy products and gastric cancer risk in Helicobacter pylori-infected subjects: a case-control study in Korea.

Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han

|Dec 23, 2022
Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity.

Sei-Yong Jun, Dae-Seong Kim, Yong-Sung Kim

|Apr 23, 2022
Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy.

Keunok Jung, Min-Jeong Son, Se-Young Lee

Pageof 4

Frequent Collaborators

5 joint publications

Chang-Soo Eun

5 joint publications

Dong-Soo Han

5 joint publications

Kyu-Sang Song

5 joint publications

Bo-Youl Choi